AbbVie Inc. Common Stock (NYSE:ABBV):
AbbVie Opens First Phase of its Global Manufacturing Facility in Singapore to Support the Growth of its Pipeline.
The company is now down by -0.54 percent from yesterday’s close.
Additionally AbbVie Inc. Common Stock recently declared a dividend paid on Monday the 15th of August 2016. The dividend was $0.570 per share for the quarter which is $2.28 annualized. This dividend amount was represent a yeild of $3.56. The ex-dividend date was set for Wednesday the 13th of July 2016.
Shares of the company are trading at $64.22 slightly below $64.90, the stock’s 50 day moving average and which is slightly above the 200 day moving average of $62.24. The 50 day moving average was down $-0.68 and the 200 day average moved up $1.98.
AbbVie Inc. Common Stock’s P/E ratio is 18.52 and market capitalization is 104.58B. In the latest earnings report the EPS was $3.47 and is estimated to be $4.81 for the current year with 1,628,542,000 shares currently outstanding. Analysts expect next quarter’s EPS to be $1.20 with next year’s EPS anticipated to be $5.66.
Several Wall Street analysts have issued ratings on AbbVie Inc. Common Stock of late. On September 8 the stock rating was downgraded from “Outperform” to “Neutral” in a statement from JP Morgan. Raymond James added ABBV to its research portfolio with an initial rating of “Outperform” and establishing a price target of $82.00.
BMO Capital downgraded the stock and lowered the price target on June 10 changing the price target from $71.00 to $65.00 and moving the rating from “Outperform” to “Equal-weight”. On June 10 the company was downgraded to “Equal-weight” from “Outperform” with a current price target of $65.00 by BMO Capital.
On June 8 the company was downgraded from “Overweight” to “Market Perform” in a report from Morgan Stanley. On June 6 the company was rated “Market Perform” in a report from Cowen & Company a cut from the previous “” rating.